{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:51:06Z","timestamp":1783468266230,"version":"3.55.0"},"reference-count":283,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.pharmthera.2023.108398","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T20:59:53Z","timestamp":1680123593000},"page":"108398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The pathomimetic oA\u03b225\u201335 model of Alzheimer's disease: Potential for screening of new therapeutic agents"],"prefix":"10.1016","volume":"245","author":[{"given":"Geoffrey","family":"Canet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charleine","family":"Zussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Desrumaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Givalois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108398_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(94)90193-7","article-title":"Administration of amyloid \u03b2-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo","volume":"636","author":"Abe","year":"1994","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0306-4522(90)90244-X","article-title":"Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system","volume":"39","author":"Ahima","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/endo-129-1-226","article-title":"Differential corticosteroid regulation of type ii glucocorticoid receptor-like immunoreactivity in the rat central nervous system: Topography and implications","volume":"129","author":"Ahima","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nbd.2005.05.001","article-title":"Impaired metabotropic glutamate receptor\/phospholipase C signaling pathway in the cerebral cortex in Alzheimer\u2019s disease and dementia with Lewy bodies correlates with stage of Alzheimer\u2019s-disease-related changes","volume":"20","author":"Albasanz","year":"2005","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0030","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1021\/acs.inorgchem.6b01733","article-title":"Zinc(II) binding site to the amyloid-\u03b2 peptide: Insights from spectroscopic studies with a wide series of modified peptides","volume":"55","author":"Alies","year":"2016","journal-title":"Inorganic Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bib1476","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2010.02.028","article-title":"Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase","volume":"210","author":"Alkam","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbr.2007.03.001","article-title":"A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by A\u03b225\u201335","volume":"180","author":"Alkam","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0040","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0028-3908(99)00044-1","article-title":"Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: Exacerbation by selective inhibition of group I metabotropic glutamate receptors","volume":"38","author":"Allen","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0045","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of \u03c4 into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proceedings. National Academy of Sciences. United States of America"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0050","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cne.902400104","article-title":"An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat","volume":"240","author":"Amaral","year":"1985","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nbd.2008.05.012","article-title":"Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats","volume":"31","author":"Arancibia","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jnr.490410416","article-title":"Beta-amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices","volume":"41","author":"Arias","year":"1995","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0075","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuroscience.2009.08.063","article-title":"Effects of memantine on soluble \u0391\u03b225-35-induced changes in peptidergic and glial cells in Alzheimer\u2019s disease model rat brain regions","volume":"164","author":"Arif","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0080","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1471-4159.1987.tb05724.x","article-title":"Molecular forms of Butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system","volume":"48","author":"Atack","year":"1987","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/nep149","article-title":"Protective effects of Rosa damascena and its active constituent on A\u03b2(25-35)-induced Neuritic atrophy","volume":"2011","author":"Awale","year":"2011","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0891-5849(02)00780-3","article-title":"Oxidatively modified proteins in aging and disease","volume":"32","author":"Beal","year":"2002","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0100","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1073\/pnas.88.16.7247","article-title":"An in vivo model for the neurodegenerative effects of \u03b2 amyloid and protection by substance P","volume":"88","author":"Kowall","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0105","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s007020070021","article-title":"Apoptosis and Alzheimer\u2019s disease","volume":"107","author":"Behl","year":"2000","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1155","article-title":"Calcium signalling: Dynamics, homeostasis and remodelling","volume":"4","author":"Berridge","year":"2003","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108398_bb0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2013.12.009","article-title":"Genetic mouse models of ageing and Alzheimer\u2019s disease","volume":"142","author":"Bilke-Gorzo","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-7-23","article-title":"Absence of amyloid \u03b2 oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer\u2019s disease neuropathology","volume":"7","author":"Bjorklund","year":"2012","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0130","first-page":"54","article-title":"Neuroprotective effect of a new photobiomodulation technique against A\u03b2 25\u201335 peptide\u2013induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer\u2019s disease suggested","volume":"4","author":"Blivet","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0135","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","article-title":"Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance","volume":"28","author":"Bolmont","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00441-014-1798-8","article-title":"Network-wide dysregulation of calcium homeostasis in Alzheimer\u2019s disease","volume":"357","author":"Brawek","year":"2014","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0145","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.neurobiolaging.2012.11.015","article-title":"Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer\u2019s disease rat model","volume":"34","author":"Brureau","year":"2013","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0150","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","article-title":"\u03b2-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding","volume":"14","author":"Busciglio","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2009.10.035","article-title":"In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP","volume":"48","author":"Butterfield","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0160","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0047-6374(01)00249-4","article-title":"Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins","volume":"122","author":"Butterfield","year":"2001","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbadis.2011.01.007","article-title":"Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer\u2019s disease neurons","volume":"1812","author":"Calkins","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0175","series-title":"Pathology, prevention and therapeutics of neurodegenerative disease","first-page":"173","article-title":"Targeting glucocorticoid receptors: A new avenue for Alzheimer\u2019s disease therapy","author":"Canet","year":"2019"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0180","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fnins.2018.00739","article-title":"Central role of glucocorticoid receptors in Alzheimer\u2019s disease and depression","volume":"12","author":"Canet","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnagi.2019.00269","article-title":"Is AD a stress-related disorder? Focus on the HPA Axis and its promising therapeutic targets","volume":"11","author":"Canet","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0190","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1096\/fj.201900723RRR","article-title":"Glucocorticoid receptors signaling impairment potentiates amyloid-\u03b2 oligomers-induced pathology in an acute model of Alzheimer\u2019s disease","volume":"34","author":"Canet","year":"2020","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1478","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1159\/000521559","article-title":"Chronic glucocorticoids consumption triggers and worsens experimental Alzheimer\u2019s disease-like pathology by detrimental immune modulations","volume":"112","author":"Canet","year":"2022","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0195","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/nbdi.2002.0516","article-title":"\u03b2-Amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons","volume":"10","author":"Casley","year":"2002","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0200","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.3390\/ijms22126577","article-title":"Early effects of the soluble amyloid \u03b225-35 peptide in rat cortical neurons: Modulation of signal transduction mediated by adenosine and group I metabotropic glutamate receptors","volume":"22","author":"Castillo","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/exnr.2000.7325","article-title":"Amyloid-\u03b2 injection in rat amygdala alters tau protein but not mRNA expression","volume":"162","author":"Chambers","year":"2000","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/jpet.109.162164","article-title":"Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer\u2019s disease","volume":"332","author":"Chavant","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0215","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101133","article-title":"Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer\u2019s disease","volume":"22","author":"Chen","year":"2019","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/syn.20599","article-title":"Amyloid \u03b2-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo","volume":"63","author":"Cheng","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lfs.2018.07.016","article-title":"Asiatic acid protects differentiated PC12 cells from A\u03b225\u201335-induced apoptosis and tau hyperphosphorylation via regulating PI3K\/Akt\/GSK-3\u03b2 signaling","volume":"208","author":"Cheng","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111571","article-title":"Protective effects of protocatechuic acid against cognitive impairment in an amyloid beta-induced Alzheimer\u2019s disease mouse model","volume":"144","author":"Choi","year":"2020","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nutres.2014.06.008","article-title":"Oligonol improves memory and cognition under an amyloid \u03b225-35\u2013induced Alzheimer\u2019s mouse model","volume":"34","author":"Choi","year":"2014","journal-title":"Nutrition Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0260","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1038\/srep07608","article-title":"Combining two repurposed drugs as a promising approach for Alzheimer\u2019s disease therapy","volume":"5","author":"Chumakov","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0265","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-\u03b2 metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nan.12197","article-title":"Invited review: Prion-like transmission and spreading of tau pathology: Prion-like transmission and spreading of tau pathology","volume":"41","author":"Clavaguera","year":"2015","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0275","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.febslet.2005.04.041","article-title":"A\u03b2(31-35) and A\u03b2(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: Role of the redox state of methionine-35","volume":"579","author":"Clementi","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02740836","article-title":"A potential role for apoptosis in neurodegeneration and Alzheimer\u2019s disease","volume":"10","author":"Cotman","year":"1995","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0290","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/ijnp\/pyaa075","article-title":"Anti-amnesic and neuroprotective effects of Fluoroethylnormemantine in a pharmacological mouse model of Alzheimer\u2019s disease","volume":"24","author":"Couly","year":"2021","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0295","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1023\/A:1021942109490","article-title":"Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: Evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor","volume":"22","author":"Cowburn","year":"1997","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0300","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nlm.2018.02.014","article-title":"Topographical memory analyzed in mice using the hamlet test, a novel complex maze","volume":"149","author":"Crouzier","year":"2018","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Alzheimer\u2019s disease","volume":"351","author":"Cummings","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0310","article-title":"Alzheimer\u2019s disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0315","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"D\u2019Agostino","year":"2012","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A2a receptor antagonists prevent \u03b2-amyloid (25\u201335)-induced cognitive deficits in mice","volume":"203","author":"Dall\u2019Igna","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0325","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.bmc.2006.02.021","article-title":"On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases","volume":"14","author":"Darvesh","year":"2006","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0330","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","article-title":"A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer\u2019s disease","volume":"78","author":"Davies","year":"1987","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0335","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019s disease","volume":"308","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0340","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"A\u03b2 oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug Memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00922-3","article-title":"In vitro aggregation facilitates \u03b2-amyloid peptide-(25-35)-induced amnesia in the rat","volume":"319","author":"Delobette","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9546761","article-title":"CZYH alleviates \u03b2-amyloid-induced cognitive impairment and inflammation response via modulation of JNK and NF-\u03baB pathway in rats","volume":"2019","author":"Deng","year":"2019","journal-title":"Behavioural Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0355","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/npp.2012.247","article-title":"Increased amyloid-\u03b2 peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice","volume":"38","author":"Desrumaux","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0360","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.174.4011.788","article-title":"The cholinergic synapse and the site of memory","volume":"174","author":"Deutsch","year":"1971","journal-title":"Science (80-.)"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0380","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.jmedchem.7b01760","article-title":"Structure\u2013Activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles","volume":"61","author":"Dolles","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system: A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0390","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","article-title":"Tau protein function in living cells","volume":"103","author":"Drubin","year":"1986","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0395","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.neuroscience.2010.02.055","article-title":"Mice knock out for the histone acetyltransferase p300\/CREB binding protein-associated factor develop a resistance to amyloid toxicity","volume":"167","author":"Duclot","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0197-4580(01)00255-X","article-title":"Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain","volume":"23","author":"Dudas","year":"2002","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0405","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.brainresbull.2018.01.001","article-title":"ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer\u2019s disease","volume":"137","author":"Esmaeili","year":"2018","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0410","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1556\/2060.103.2016.3.7","article-title":"Intranasal insulin treatment improves memory and learning in a rat amyloid-beta model of Alzheimer\u2019s disease","volume":"103","author":"Farzampour","year":"2016","journal-title":"Physiology International"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0420","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.biopha.2016.08.065","article-title":"Ropren\u00ae treatment reverses anxiety-like behavior and monoamines levels in gonadectomized rat model of Alzheimer\u2019s disease","volume":"83","author":"Fedotova","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0425","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2011.12.008","article-title":"Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of \u03b2-amyloid and ibotenic acid into the bilateral hippocampus","volume":"423","author":"Feng","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0430","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nbd.2003.12.006","article-title":"\u03b2-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: Modulation of uptake as a survival mechanism","volume":"15","author":"Fern\u00e1ndez-Tom\u00e9","year":"2004","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/089198870101400111","article-title":"Anxiety and Alzheimer\u2019s disease","volume":"14","author":"Ferretti","year":"2001","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0440","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuroscience.2019.09.032","article-title":"Curcumin-loaded Nanocapsules reverses the depressant-like behavior and oxidative stress induced by \u03b2-amyloid in mice","volume":"423","author":"Fidelis","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0445","article-title":"Apoptosis mediated neurotoxicity induced by chronic application of \u03b2 amyloid fragment 25-35","volume":"523\u2013526","author":"Forloni","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0450","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11130-020-00816-0","article-title":"Dehydroeffusol rescues amyloid \u03b225\u201335-induced spatial working memory deficit","volume":"75","author":"Fukuda","year":"2020","journal-title":"Plant Foods for Human Nutrition"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0455","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1471-4159.2004.02828.x","article-title":"Interaction of human and mouse A\u03b2 peptides","volume":"91","author":"Fung","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0460","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1046\/j.1471-4159.1998.71052034.x","article-title":"Increased nuclear DNA oxidation in the brain in Alzheimer\u2019s disease","volume":"71","author":"Gabbita","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0465","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0197-4580(87)90072-8","article-title":"Calcium and the aging nervous system","volume":"8","author":"Gibson","year":"1987","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0470","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0306-4522(94)00610-H","article-title":"Differential effects of amyloid peptides \u03b2-(1-40) and \u03b2-(25-35) injections into the rat nucleus basalis","volume":"66","author":"Giovannelli","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0475","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-017-9838-2","article-title":"Sigma-1 receptor agonists induce oxidative stress in mitochondria and enhance complex I activity in physiological condition but protect against pathological oxidative stress","volume":"35","author":"Goguadze","year":"2019","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0485","first-page":"1","article-title":"Post-mortem analysis of neuroinflammatory changes in human Alzheimer\u2019s disease","volume":"7","author":"Gomez-Nicola","year":"2015","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0490","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0306-4522(02)00241-5","article-title":"Characterization of neuronal dystrophy induced by fibrillar amyloid \u03b2: Implications for Alzheimer\u2019s disease","volume":"114","author":"Grace","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(95)00669-H","article-title":"Neurodegeneration mediated by glutamate and \u03b2-amyloid peptide: A comparison and possible interaction","volume":"691","author":"Gray","year":"1995","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2007.03.023","article-title":"Differential neuroimmune markers to the onset of Alzheimer\u2019s disease neurodegeneration and dementia: Autoantibodies to Abeta(25-35) oligomers, S100b and neurotransmitters","volume":"186","author":"Gruden","year":"2007","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0505","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated proteins","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bib1479","doi-asserted-by":"crossref","first-page":"101378","DOI":"10.1016\/j.redox.2019.101378","article-title":"7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo","volume":"29","author":"Gunesch","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.pharmthera.2023.108398_bb0510","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/1673-5374.295339","article-title":"Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice","volume":"16","author":"Gutierrez","year":"2021","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0515","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0520","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3233\/ADR-210035","article-title":"Neuronal deposition of amyloid-\u03b2 oligomers and hyperphosphorylated tau is closely connected with cognitive dysfunction in aged dogs","volume":"5","author":"Habiba","year":"2021","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0525","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neures.2004.12.013","article-title":"Colocalization of mineralocorticoid receptor and glucocorticoid receptor in the hippocampus and hypothalamus","volume":"51","author":"Han","year":"2005","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0530","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0535","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0540","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1471-4159.1996.67010277.x","article-title":"Amyloid \u03b2 peptide (25-35) inhibits Na+\u2212dependent glutamate uptake in rat hippocampal astrocyte cultures","volume":"67","author":"Harris","year":"1996","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0545","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0197-4580(97)80309-0","article-title":"Twenty-four hour cortisol release profiles in patients with Alzheimer\u2019s and Parkinson\u2019s disease compared to Normal controls: Ultradian secretory Pulsatility and diurnal variation","volume":"18","author":"Hartmann","year":"1997","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0550","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.jmedchem.0c01940","article-title":"Melatonin- and Ferulic acid-based HDAC6 selective inhibitors exhibit pronounced immunomodulatory effects in vitro and neuroprotective effects in a pharmacological Alzheimer\u2019s disease mouse model","volume":"64","author":"He","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0555","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainresrev.2009.11.004","article-title":"Neuroglia in neurodegeneration","volume":"63","author":"Heneka","year":"2010","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0560","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001756-200002280-00001","article-title":"Dynorphin A-(1\u221213) and (2\u221213) improve \u03b2-amyloid peptide-induced amnesia in mice","volume":"11","author":"Hiramatsu","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0565","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective Butyrylcholinesterase inhibitors with Tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer\u2019s disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0570","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1021691918517","article-title":"Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits","volume":"29","author":"Holcomb","year":"1999","journal-title":"Behavior Genetics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0575","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neurobiolaging.2003.04.005","article-title":"Pathology of presynaptic proteins in Alzheimer\u2019s disease: More than simple loss of terminals","author":"Honer","year":"2003","journal-title":"Neurobiology of Aging (Elsevier Inc.)"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0580","doi-asserted-by":"crossref","first-page":"780.e1","DOI":"10.1016\/j.neurobiolaging.2005.07.017","article-title":"Increased cerebrospinal fluid cortisol level in Alzheimer\u2019s disease is not related to depression","volume":"27","author":"Hoogendijk","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0585","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0590","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early A\u03b2 accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0595","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(86)92134-3","article-title":"Defective brain microtubule assembly in Alzheimer\u2019s disease","volume":"2","author":"Iqbal","year":"1986","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0605","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12272-017-0893-2","article-title":"Phytoceramide ameliorates \u00df-amyloid protein-induced memory impairment and neuronal death in mice","volume":"40","author":"Jang","year":"2017","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0610","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.biopha.2018.10.189","article-title":"Neuroprotective effects of 1`\u03b4-1`-acetoxyeugenol acetate on A\u03b2(25-35) induced cognitive dysfunction in mice","volume":"109","author":"Jayasingh Chellammal","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0615","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/jnr.22159","article-title":"Fustin flavonoid attenuates \u03b2-amyloid (1-42)-induced learning impairment","volume":"87","author":"Jin","year":"2009","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0620","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1745-7254.2005.00158.x","article-title":"Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1\/2 and Akt\/protein kinase B in rat hippocampus1","volume":"26","author":"Jin","year":"2005","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0625","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/10715760802159057","article-title":"Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo","volume":"42","author":"Kaminsky","year":"2008","journal-title":"Free Radical Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0630","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2009.09.005","article-title":"Subcellular and metabolic examination of amyloid-\u03b2 peptides in Alzheimer disease pathogenesis: Evidence for A\u03b225\u201335","volume":"221","author":"Kaminsky","year":"2010","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0635","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1021\/acs.jpcb.7b07002","article-title":"Membrane binding and pore formation by a cytotoxic fragment of amyloid \u03b2 peptide","volume":"121","author":"Kandel","year":"2017","journal-title":"The Journal of Physical Chemistry. B"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0640","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0306-4522(01)00155-5","article-title":"Drastic neuronal loss in vivo by \u03b2-amyloid racemized at Ser26 residue: Conversion of non-toxic [D-Ser26]\u03b2-amyloid 1-40 to toxic and proteinase-resistant fragments","volume":"104","author":"Kaneko","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0645","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bpa.12734","article-title":"A\u03b2 oligomers trigger and accelerate A\u03b2 seeding","volume":"30","author":"Katzmarski","year":"2020","journal-title":"Brain Pathology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0650","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-215662","article-title":"Lipid rafts act as a common platform for amyloid-\u03b2 oligomer-induced Alzheimer\u2019s disease pathology","volume":"87","author":"Kawarabayashi","year":"2022","journal-title":"JAD"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0655","author":"Khachaturian","year":"1989","journal-title":"The role of calcium regulation in brain aging: reexamination of a hypothesis."},{"key":"10.1016\/j.pharmthera.2023.108398_bb0660","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2008.05.019","article-title":"The effects of acute and repeated oroxylin A treatments on A\u03b225\u201335-induced memory impairment in mice","volume":"55","author":"Kim","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0665","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1089\/jmf.2015.3443","article-title":"Ilex latifolia prevents amyloid \u03b2 protein (25-35)-induced memory impairment by inhibiting apoptosis and tau phosphorylation in mice","volume":"18","author":"Kim","year":"2015","journal-title":"Journal of Medicinal Food"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0670","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroscience.2006.11.060","article-title":"A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by A\u03b225-35","volume":"145","author":"Klementiev","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0675","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: From adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0680","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pnpbp.2017.05.007","article-title":"Molecular imaging of neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment","volume":"80","author":"Knezevic","year":"2018","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0685","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/brain\/awv137","article-title":"Accumulation of murine amyloid-\u03b2 mimics early Alzheimer\u2019s disease","volume":"138","author":"Krohn","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0690","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jnr.10391","article-title":"In vivo conversion of racemized \u03b2amyloid ([D-Ser26]A\u03b21-40) to truncated and toxic fragments ([D-Ser26]A\u03b225-35\/40) and fragment presence in the brains of Alzheimer\u2019s patients","volume":"70","author":"Kubo","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0695","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjp.0706122","article-title":"Neuritic regeneration and synaptic reconstruction induced by withanolide A","volume":"144","author":"Kuboyama","year":"2005","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0700","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","article-title":"Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism","volume":"156","author":"Kuo","year":"2000","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0705","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00702-017-1731-x","article-title":"In vivo PET imaging of neuroinflammation in Alzheimer\u2019s disease","volume":"125","author":"Lagarde","year":"2018","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00463","volume":"8","author":"Lahmy","year":"2015","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0720","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of tau hyperphosphorylation and a\u03b2 1-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c3 1 receptor agonist, in a nontransgenic mouse model of Alzheimer\u2019s disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0725","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.651094","article-title":"Subcommissural organ-Spondin-derived peptide restores memory in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Le Douce","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0735","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1089\/jmf.2016.3737","article-title":"Effects of vegetable oils with different fatty acid compositions on cognition and memory ability in A \u03b2 25\u201335 -induced Alzheimer\u2019s disease mouse model","volume":"19","author":"Lee","year":"2016","journal-title":"Journal of Medicinal Food"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0740","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2020.9192","article-title":"Beneficial effect of black rice (Oryza sativa L. var. japonica) extract on amyloid &beta;-induced cognitive dysfunction in a mouse model","volume":"20","author":"Lee","year":"2020","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0745","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1021\/acs.jafc.7b03941","article-title":"Alpha-linolenic acid from Perilla frutescens var. japonica oil protects A\u03b2-induced cognitive impairment through regulation of APP processing and A\u03b2 degradation","volume":"65","author":"Lee","year":"2017","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0750","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"33","author":"Lee","year":"2010","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0755","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12011-017-1162-4","article-title":"Selenium and zinc against A\u03b225\u201335-induced cytotoxicity and tau phosphorylation in PC12 cells and inhibits \u03b3-cleavage of APP","volume":"184","author":"Li","year":"2018","journal-title":"Biological Trace Element Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0765","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neures.2008.11.006","article-title":"Amyloid-\u03b225-35impairs memory and increases NO in the temporal cortex of rats","volume":"63","author":"Lim\u00f3n","year":"2009","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8148156","article-title":"Crocin improves cognitive behavior in rats with Alzheimer\u2019s disease by regulating endoplasmic reticulum stress and apoptosis","volume":"2019","author":"Lin","year":"2019","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0775","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0196-9781(02)00057-8","article-title":"Electrophysiologic properties of channels induced by A\u03b225-35 in planar lipid bilayers","volume":"23","author":"Lin","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0780","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2012.11.018","article-title":"Quercetin protects against the A\u03b225\u201335-induced amnesic injury: Involvement of inactivation of RAGE-mediated pathway and conservation of the NVU","volume":"67","author":"Liu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0785","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/01616412.2017.1317916","article-title":"The PTEN inhibitor bpV(pic) promotes neuroprotection against amyloid \u03b2-peptide (25-35)-induced oxidative stress and neurotoxicity","volume":"39","author":"Liu","year":"2017","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0790","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-200499","article-title":"Dietary pattern, diet quality, and dementia: A systematic review and meta-analysis of prospective cohort studies","volume":"78","author":"Liu","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0795","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jnr.490390416","article-title":"Inhibitors of free radical formation fail to attenuate direct \u03b2-amyloid25\u201335 peptide-mediated neurotoxicity in rat hippocampal cultures","volume":"39","author":"Lockhart","year":"1994","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0800","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer\u2019s disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0805","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.109.155069","article-title":"Silibinin attenuates amyloid \u03b2 25\u201335 peptide-induced memory impairments: Implication of inducible nitric-oxide synthase and tumor necrosis factor-\u03b1 in mice","volume":"331","author":"Lu","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0810","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0815","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12944-018-0708-6","article-title":"Possible mechanism of Vitis vinifera L. flavones on neurotransmitters, synaptic transmission and related learning and memory in Alzheimer model rats","volume":"17","author":"Ma","year":"2018","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0825","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000080991","article-title":"Cerebrospinal fluid profile of amyloid \u03b2 peptides in patients with Alzheimer\u2019s disease determined by protein biochip technology","volume":"1","author":"Maddalena","year":"2004","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0830","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1248\/bpb.27.1041","article-title":"Effects of pre-germinated brown rice on .BETA.-amyloid protein-induced learning and memory deficits in mice","volume":"27","author":"Mamiya","year":"2004","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0835","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11055-010-9320-6","article-title":"Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer\u2019s disease by adaptation to hypoxia","volume":"40","author":"Manukhina","year":"2010","journal-title":"Neuroscience and Behavioral Physiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107861","article-title":"Dietary nutrition for neurological disease therapy: Current status and future directions","volume":"226","author":"Mao","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0845","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: Implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0850","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0855","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0006-8993(98)00763-X","article-title":"Amyloid \u03b2-peptide induces apoptosis-related events in synapses and dendrites","volume":"807","author":"Mattson","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0860","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0865","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0006-8993(96)00710-X","article-title":"Reversion of beta 25-35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists","volume":"731","author":"Maurice","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0870","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/0269881113494939","article-title":"Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the A\u03b2 25-35 non-transgenic mouse model of Alzheimer\u2019s disease","volume":"27","author":"Maurice","year":"2013","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0875","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2015.08.026","article-title":"Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse","volume":"296","author":"Maurice","year":"2016","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bib1477","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","article-title":"Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate \u03b225-35-amyloid peptide-induced amnesia in mice through a common mechanism","volume":"83","author":"Maurice","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0880","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.phrs.2019.04.026","article-title":"Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer\u2019s disease by positive modulation of \u03c31 receptors","volume":"144","author":"Maurice","year":"2019","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0885","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0890","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.410360510","article-title":"Oxidative damage to mitochondrial DNA is increased in Alzheimer\u2019s disease","volume":"36","author":"Mecocci","year":"1994","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0895","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.69204","article-title":"The cholinergic lesion of Alzheimer\u2019s disease: Pivotal factor or side show?","volume":"11","author":"Mesulam","year":"2004","journal-title":"Learning & Memory"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0900","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1002\/cne.23415","article-title":"Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer\u2019s disease","volume":"521","author":"Mesulam","year":"2013","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0905","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410360506","article-title":"Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia","volume":"36","author":"Mesulam","year":"1994","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0910","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0915","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2012.10.033","article-title":"The \u03b3-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl)amino]ethyl-5-fluorobenzenebu-tanoic acid (BMS-299897) alleviates A\u03b21\u201342 seeding and short-term memory deficits in the A\u03b225\u201335 mouse model of Alzheimer\u2019s disease","volume":"698","author":"Meunier","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0920","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/138920310790274626","article-title":"Conformations and biological activities of amyloid beta peptide 25-35","volume":"11","author":"Millucci","year":"2010","journal-title":"Current Protein & Peptide Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0925","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1006\/bbrc.1994.2047","article-title":"Channel formation in planar lipid bilayers by a neurotoxic fragment of the \u03b2-amyloid peptide","volume":"202","author":"Mirzabekov","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107480","article-title":"Natural products-bases polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders","volume":"208","author":"Mok","year":"2020","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0935","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.expneurol.2006.02.126","article-title":"Role of oxidative stress on \u03b2-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: Protection by antioxidants","volume":"200","author":"Montiel","year":"2006","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0940","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1023\/A:1015536808304","article-title":"Amyloid \u03b2-peptide promotes permeability transition pore in brain mitochondria","volume":"21","author":"Moreira","year":"2001","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0945","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1471-4159.2004.02451.x","article-title":"MGLuR5 activation reduces \u03b2-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor","volume":"89","author":"Movsesyan","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0950","article-title":"Microglia in Alzheimer brain: A neuropathological perspective","volume":"2012","author":"Mrak","year":"2012","journal-title":"International Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0955","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.euroneuro.2015.03.018","article-title":"Leucettine L41, a DYRK1A-preferential DYRKs\/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric A\u03b225-35 peptide administration in mice","volume":"25","author":"Naert","year":"2015","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0960","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2147\/DDDT.S289473","article-title":"Epigallocatechin-3-Gallate provides protection against Alzheimer\u2019s disease-induced learning and memory impairments in rats","volume":"15","author":"Nan","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0965","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2739","article-title":"Dendrobium alkaloids prevent A\u03b2 25\u201335 -induced neuronal and synaptic loss via promoting neurotrophic factors expression in mice","volume":"4","author":"Nie","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0970","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1080\/13880209.2017.1302967","article-title":"Gelidiella acerosa protects against A\u03b2 25-35-induced toxicity and memory impairment in Swiss albino mice: An in vivo report","volume":"55","author":"Nisha","year":"2017","journal-title":"Pharmaceutical Biology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0975","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","article-title":"RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease","volume":"19","author":"Nunomura","year":"1999","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0980","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s007020170025","article-title":"Memory deficits and increased emotionality induced by \u03b2-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus","volume":"108","author":"Olariu","year":"2001","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0990","doi-asserted-by":"crossref","DOI":"10.1002\/alz.036167","article-title":"NeuroEPO in mild-to-moderate Alzheimer\u2019s disease: Human\/human trials: Cognitive enhancement","volume":"16","author":"P\u00e9rez","year":"2020","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.pharmthera.2023.108398_bb0995","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3233\/JAD-150896","article-title":"Differential membrane toxicity of amyloid-\u03b2 fragments by pore forming mechanisms","volume":"51","author":"Peters","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1000","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00001756-199209000-00012","article-title":"\u03bc-Amyloid induces neuritic dystrophy in vitro: Similarities with alzherimer pathology","volume":"3","author":"Pike","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1471-4159.1995.64010253.x","article-title":"Structure-activity analyses of beta-amyloid peptides\u00a0: Contributions of the beta 25-35 region to aggregation and neurotoxicity","volume":"64","author":"Pike","year":"1995","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2016.05.018","article-title":"New selective glucocorticoid receptor modulators reverse amyloid-\u03b2 peptide\u2013induced hippocampus toxicity","volume":"45","author":"Pineau","year":"2016","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ddr.10100","article-title":"Role of GSK-3\u03b2 in Alzheimer\u2019s disease pathology","volume":"56","author":"Planel","year":"2002","journal-title":"Drug Development Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt232","article-title":"Photobiomodulation with near infrared light mitigates Alzheimer\u2019s disease-related pathology in cerebral cortex \u2013 Evidence from two transgenic mouse models","volume":"6","author":"Purushothuman","year":"2014","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer\u2019s disease: Implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1045","doi-asserted-by":"crossref","first-page":"33172","DOI":"10.1038\/srep33172","article-title":"In vivo characterization of ARN14140, a Memantine\/Galantamine-based multi-target compound for Alzheimer\u2019s disease","volume":"6","author":"Reggiani","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1050","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/jcb.23062","article-title":"Effect of \u03b2-amyloid (25-35) on mitochondrial function and expression of mitochondrial permeability transition pore proteins in rat hippocampal neurons","volume":"112","author":"Ren","year":"2011","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid \u03b2 oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2007.01.071","article-title":"Susceptibility of hippocampal neurons to A\u03b2 peptide toxicity is associated with perturbation of Ca2+ homeostasis","volume":"1143","author":"Resende","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1065","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/endo-117-6-2505","article-title":"Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation","volume":"117","author":"Reul","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.phrs.2016.11.013","article-title":"Metabotropic glutamate receptors and neurodegenerative diseases","volume":"115","author":"Ribeiro","year":"2017","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An intranasal formulation of erythropoietin (neuro-EPO) prevents memory deficits and amyloid toxicity in the APPSwe transgenic mouse model of Alzheimer\u2019s disease","volume":"55","author":"Rodr\u00edguez Cruz","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1080","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/anie.200802808","article-title":"Alzheimer\u2019s disease: From pathology to therapeutic approaches","volume":"48","author":"Roland","year":"2009","journal-title":"Angewandte Chemie, International Edition"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1085","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/756357","article-title":"A review: Inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.pharmthera.2023.108398_bb1090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35014735","article-title":"Presenilin-1 mutations in Alzheimer\u2019s disease","volume":"405","author":"Russo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1095","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1007\/s12035-017-0852-4","article-title":"Brain Photobiomodulation therapy: A narrative review","volume":"55","author":"Salehpour","year":"2018","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2008.10.048","article-title":"Subregion-specific differences in translocation patterns of mineralocorticoid and glucocorticoid receptors in rat hippocampus","volume":"1249","author":"Sarabdjitsingh","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1110","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1115","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1120","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1021\/acs.jmedchem.9b00623","article-title":"Dual-acting cholinesterase\u2013human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo","volume":"62","author":"Scheiner","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111186","article-title":"Strength training or green tea prevent memory deficits in a \u03b2-amyloid peptide-mediated Alzheimer\u2019s disease model","volume":"143","author":"Schimidt","year":"2021","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1130","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.3390\/ijms22115991","article-title":"An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity?","volume":"22","author":"Sciaccaluga","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2011.12.057","article-title":"Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease","volume":"51","author":"Selfridge","year":"2013","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1140","doi-asserted-by":"crossref","DOI":"10.1038\/scientificamerican1191-68","article-title":"Amyloid protein and Alzheimer\u2019s disease","volume":"265","author":"Selkoe","year":"1991","journal-title":"Scientific American"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: Genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1155","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.abi6401","article-title":"Treatments for Alzheimer\u2019s disease emerge","volume":"373","author":"Selkoe","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1471-4159.1988.tb13231.x","article-title":"Neuritic plaque amyloid in Alzheimer\u2019s disease is highly racemized","volume":"50","author":"Shapira","year":"1988","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1170","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/(SICI)1097-4547(19970915)49:6<759::AID-JNR10>3.0.CO;2-N","article-title":"\u03b2-Amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: Differential involvement of the calpain\/protein kinase C system","volume":"49","author":"Shea","year":"1997","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-079x.2002.1819.x","article-title":"The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25-35 in middle-aged rats","volume":"32","author":"Shen","year":"2002","journal-title":"Journal of Pineal Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuint.2012.04.019","article-title":"The protective effects of tanshinone IIA on neurotoxicity induced by \u03b2-amyloid protein through calpain and the p35\/Cdk5 pathway in primary cortical neurons","volume":"61","author":"Shi","year":"2012","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/35086072","article-title":"Alzheimer\u2019s disease and A toxicity: From top to bottom","volume":"2","author":"Small","year":"2001","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopha.2016.06.021","article-title":"Pelargonidin improves memory deficit in amyloid \u03b225-35 rat model of Alzheimer\u2019s disease by inhibition of glial activation, cholinesterase, and oxidative stress","volume":"83","author":"Sohanaki","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1200","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11064-016-2141-4","article-title":"Silibinin ameliorates A\u03b225-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress","volume":"42","author":"Song","year":"2017","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1602\/neurorx.2.3.423","article-title":"Transgenic models of Alzheimer\u2019s disease: Learning from animals","volume":"2","author":"Spires","year":"2005","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2013.11.013","article-title":"Transient disturbances in contextual fear memory induced by A\u03b2(25\u201335) in rats are accompanied by cholinergic dysfunction","volume":"259","author":"Stepanichev","year":"2014","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbr.2006.09.006","article-title":"Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25\u201335) on memory function and hippocampal damage in rat","volume":"175","author":"Stepanichev","year":"2006","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1220","first-page":"597","article-title":"The effect of the administration of beta-amyloid peptide fragment (25-35) on behavior in rats","volume":"47","author":"Stepanichev","year":"1997","journal-title":"Zhurnal Vysshe\u012d Nervno\u012d Deiatelnosti Imeni I P Pavlova"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0361-9230(03)00118-7","article-title":"Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats","volume":"61","author":"Stepanichev","year":"2003","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jnr.10469","article-title":"Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35)","volume":"71","author":"Stepanichev","year":"2003","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11055-005-0167-1","article-title":"Studies of the effects of central administration of \u03b2-amyloid peptide (25-35): Pathomorphological changes in the hippocampus and impairment of spatial memory","volume":"36","author":"Stepanichev","year":"2006","journal-title":"Neuroscience and Behavioral Physiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1240","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.physbeh.2003.11.003","article-title":"Amyloid-\u03b2(25-35)-induced memory impairments correlate with cell loss in rat hippocampus","volume":"80","author":"Stepanichev","year":"2004","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1245","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1529\/biophysj.108.134429","article-title":"The structure of the amyloid-\u03b2 peptide high-affinity copper II binding site in Alzheimer disease","volume":"95","author":"Streltsov","year":"2008","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1250","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1097\/00001756-199412000-00031","article-title":"Immunohistochemical evidence for apoptosis in Alzheimer\u02bcs disease","volume":"5","author":"Su","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1255","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neurobiolaging.2012.09.012","article-title":"Neuroinflammatory phenotype in early Alzheimer\u2019s disease","volume":"34","author":"Sudduth","year":"2013","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuro.2008.04.001","article-title":"A\u03b225\u201335 induces presynaptic changes in organotypic hippocampal slice cultures","volume":"29","author":"Suh","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2005.10.004","article-title":"Identification of nitrated proteins in Alzheimer\u2019s disease brain using a redox proteomics approach","volume":"22","author":"Sultana","year":"2006","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1270","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1152\/jn.00230.2001","article-title":"Impairment of hippocampal CA1 Heterosynaptic transformation and spatial memory by \u03b2-amyloid 25\u201335","volume":"87","author":"Sun","year":"2002","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.155.2.286","article-title":"Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer\u2019s disease: Lack of association between longitudinal and cross-sectional findings","volume":"155","author":"Swanwick","year":"1998","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0168-0102(98)00061-3","article-title":"Activation of tau protein kinase I\/glycogen synthase kinase-3\u03b2 by amyloid \u03b2 peptide (25-35) enhances phosphorylation of tau in hippocampal neurons","volume":"31","author":"Takashima","year":"1998","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1285","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1073\/pnas.90.16.7789","article-title":"Tau protein kinase I is essential for amyloid \u03b2-protein-induced neurotoxicity","volume":"90","author":"Takashima","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2001-3209","article-title":"Commentary: Abeta N- terminal isoforms: Critical contributors in the course of AD pathophysiology","volume":"3","author":"Tekirian","year":"2001","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1295","article-title":"Anxiety in alzheimer\u2019s disease: Prevalence and comorbidity","volume":"54","author":"Teri","year":"1999","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1300","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuint.2013.01.023","article-title":"The missing link in the amyloid cascade of Alzheimer\u2019s disease - metal ions","volume":"62","author":"Tiiman","year":"2013","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1310","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.npp.1300388","article-title":"A\u03b2(25\u201335)-induced memory impairment, axonal atrophy and synaptic loss are ameliorated by M1, A metabolite of Protopanaxadiol-type Saponins","volume":"29","author":"Tohda","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1472-6882-8-49","article-title":"Kihi-to, a herbal traditional medicine, improves Abeta(25\u201335)-induced memory impairment and losses of neurites and synapses","volume":"8","author":"Tohda","year":"2008","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1320","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(03)03449-8","article-title":"Repair of amyloid \u03b2(25\u201335)-induced memory impairment and synaptic loss by a Kampo formula","volume":"990","author":"Tohda","year":"2003","journal-title":"Zokumei-to. Brain Res."},{"key":"10.1016\/j.pharmthera.2023.108398_bb1325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1021761310435","article-title":"Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo","volume":"33","author":"Trubetskaya","year":"2003","journal-title":"Neuroscience and Behavioral Physiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1330","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2008.03.002","article-title":"Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25\u201335)","volume":"190","author":"Tsunekawa","year":"2008","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1335","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer\u2019s disease","volume":"9","author":"Tu","year":"2014","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1340","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1471-4159.1997.68010265.x","article-title":"Amyloid \u03b2 protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: A possible involvement of free radicals","volume":"68","author":"Ueda","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1345","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0079-6336(11)80102-6","article-title":"Co-localization of brain corticosteroid receptors in the rat hippocampus","volume":"26","author":"Van Eekelen","year":"1992","journal-title":"Progress in Histochemistry and Cytochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1350","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/ja010452r","article-title":"Different mechanisms of oxidative stress and neurotoxicity for Alzheimer\u2018s A\u03b2(1\u221242) and A\u03b2(25\u221235)","volume":"123","author":"Varadarajan","year":"2001","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1355","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/npp.2008.212","article-title":"Antiamnesic and neuroprotective effects of the Aminotetrahydrofuran derivative ANAVEX1-41 against amyloid \u03b225\u201335-induced toxicity in mice","volume":"34","author":"Villard","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1360","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0269881110379286","article-title":"Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor\/sigma 1 (\u03c31) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative","volume":"25","author":"Villard","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1365","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1370","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1210\/en.2011-0145","article-title":"Glucocorticoids facilitate astrocytic amyloid-\u03b2 peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-\u03b2-degrading proteases","volume":"152","author":"Wang","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1375","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopha.2018.07.149","article-title":"Akebia saponin D reverses corticosterone hypersecretion in an Alzheimer\u2019s disease rat model","volume":"107","author":"Wang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1380","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/706487","article-title":"New treatment for alzheimer\u2019s disease, kamikihito, reverses amyloid- \u03b2 -induced progression of tau phosphorylation and axonal atrophy","volume":"2014","author":"Watari","year":"2014","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1385","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1179\/016164105X49436","article-title":"Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer\u2019s disease","volume":"27","author":"Watson","year":"2005","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1390","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1529\/biophysj.105.079186","article-title":"Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide","volume":"91","author":"Wei","year":"2006","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1395","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1400","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1405","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","article-title":"Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation","volume":"81","author":"Wiltfang","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1410","first-page":"217","article-title":"Amyloid \u03b2 protein injection into medial septum impairs hippocampal long-term potentiation and cognitive behaviors in rats","volume":"70","author":"Wu","year":"2018","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1415","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7258(00)00081-4","article-title":"Animal models of Alzheimer\u2019s disease and evaluation of anti-dementia drugs","volume":"88","author":"Yamada","year":"2000","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1420","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(01)00730-0","article-title":"Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat","volume":"412","author":"Yamaguchi","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1425","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.7150\/thno.70756","article-title":"Non-invasive photobiomodulation treatment in an Alzheimer disease-like transgenic rat model","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1430","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1126\/science.2474201","article-title":"Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer\u2019s disease","volume":"245","author":"Yankner","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid \u00df protein\u00a0: Reversal by tachykinin neuropeptides","volume":"250","author":"Yankner","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1440","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2014.09.027","article-title":"Sigma-1 (\u03c31) receptor deficiency reduces \u03b2-amyloid25\u201335-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B","volume":"89","author":"Yin","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1445","article-title":"Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1450","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4103\/1673-5374.211193","article-title":"Protective effects of Dendrobium nobile Lindl. Alkaloids on amyloid beta (25\u201335)-induced neuronal injury","volume":"12","author":"Zhang","year":"2017","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1455","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00213-015-4133-5","article-title":"A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves A\u03b225-35-impaired mouse cognitive function","volume":"233","author":"Zhang","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1460","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1465","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajpath.2011.03.021","article-title":"Time-course and regional analyses of the Physiopathological changes induced after cerebral injection of an amyloid \u03b2 fragment in rats","volume":"179","author":"Zussy","year":"2011","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053117","article-title":"Alzheimer\u2019s disease related markers, cellular toxicity and Behavioral deficits induced six weeks after oligomeric amyloid-\u03b2 peptide injection in rats","volume":"8","author":"Zussy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108398_bb1475","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/antiox11050838","article-title":"Intranasal administration of nanovectorized docosahexaenoic acid (DHA) improves cognitive function in two complementary mouse models of Alzheimer\u2019s disease","volume":"11","author":"Zussy","year":"2022","journal-title":"Antioxidants (Basel)"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:31:28Z","timestamp":1759012288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":283,"alternative-id":["S0163725823000621"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108398","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathomimetic oA\u03b225\u201335 model of Alzheimer's disease: Potential for screening of new therapeutic agents","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108398"}}